Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-41,804
Closed -$225K 6080
2025
Q3
$225K Sell
41,804
-42,001
-50% -$227K ﹤0.01% 5486
2025
Q2
$455K Sell
83,805
-1,733,179
-95% -$6.87M ﹤0.01% 4963
2025
Q1
$5.03M Buy
1,816,984
+169,947
+10% +$591K ﹤0.01% 2855
2024
Q4
$5.62M Sell
1,647,037
-771,136
-32% -$2.22M ﹤0.01% 2718
2024
Q3
$7.11M Sell
2,418,173
-454,746
-16% -$1.5M ﹤0.01% 2516
2024
Q2
$9.77M Buy
2,872,919
+111,829
+4% +$366K ﹤0.01% 2099
2024
Q1
$8.37M Buy
2,761,090
+32,187
+1% +$113K ﹤0.01% 2357
2023
Q4
$11.5M Buy
2,728,903
+920,822
+51% +$4.99M 0.01% 2054
2023
Q3
$12.3M Sell
1,808,081
-75,578
-4% -$667K 0.01% 1855
2023
Q2
$19.6M Buy
1,883,659
+93,351
+5% +$835K 0.01% 1410
2023
Q1
$12.5M Buy
1,790,308
+924,064
+107% +$8.06M 0.01% 1741
2022
Q4
$5.22M Buy
866,244
+330,212
+62% +$2.44M ﹤0.01% 2771
2022
Q3
$4.22M Buy
536,032
+1,831
+0.3% +$21.3K ﹤0.01% 3058
2022
Q2
$7.27M Sell
534,201
-44,701
-8% -$739K ﹤0.01% 2398
2022
Q1
$11.4M Buy
578,902
+355,287
+159% +$7.09M 0.01% 2014
2021
Q4
$7.67M Sell
223,615
-41,307
-16% -$1.66M ﹤0.01% 2438
2021
Q3
$14.5M Buy
264,922
+232,415
+715% +$14M 0.01% 1619
2021
Q2
$2.39M Sell
32,507
-40,728
-56% -$4.07M ﹤0.01% 3750
2021
Q1
$6.7M Buy
73,235
+61,030
+500% +$5.92M ﹤0.01% 2255
2020
Q4
$989K Sell
12,205
-292,432
-96% -$22.4M ﹤0.01% 3746
2020
Q3
$14.2K Buy
+304,637
New +$17M 0.02% 1000

Other funds holding CVAC

Israel Englander's CVAC Position: Q4 2025 in Review

Israel Englander sold out of CureVac (CVAC) in Q4 2025, closing a stake of 41,804 shares — an estimated $225K sold.

Israel Englander first reported a position in CVAC in Q3 2020 and held it in 21 quarters. The position peaked at $19.6M in Q2 2023. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

  • Israel Englander reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
  • Israel Englander sold 41,804 CureVac shares in Q4 2025, an estimated $225K.
  • Israel Englander first reported a position in CureVac in Q3 2020 and held it in 21 quarters.
  • Israel Englander's CureVac position peaked at $19.6M in Q2 2023.
  • 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.